The Clinical Spectrum of Hepatic Manifestations in Chronic Lymphocytic Leukemia
Natalia Kreiniz(Bnai Zion Medical Center), Tamar Tadmor(Bnai Zion Medical Center), Ofrat Beyar‐Katz(Rambam Health Care Campus), Aaron Polliack(Hadassah Medical Center)
Cited by 20
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
|Blood Advances|2021|170
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study
|Transplantation and Cellular Therapy|2021|164
Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells
|Cancer Research|2018|103